Analysis of the METABRIC (Curtis et al., 2012) series of 2,000 breast cancer patients revealed that high A3B expression is associated with poor survival (hazard ratio [HR] = 1.5, p = 1 × 10−11) (Figures S1A and S1B). Here, APOBEC3B is linked to breast carcinoma.